Some good news is that it shows safety, and possible efficacy.
Some bad news is that no plans were mentioned for a Phase 2 trial, only that "Patients will continue to be evaluated every six months for another five years in the study’s extension phase."
PNT article: Stem Cell Therapy Shows Safety, Possible Efficacy in Early Trial.
Encouraging.
This was quite a controversial trial initially due to a lack of preclinical evidence published before the trial. Many experts worried that it would fail dramatically and set the stem cell progress back decades. So it good news that its been discovered to be safe in the small trial and at the very least has had no negative impact.
